A compact accelerator-based neutron source has been proposed and created at the Budker Institute of Nuclear Physics in Novosibirsk, Russia. An original design tandem accelerator is used to provide a proton beam. The proton beam energy can be varied within a range of 0.6–2.3 MeV, keeping a high-energy stability of 0.1%. The beam current can also be varied in a wide range (from 0.3 mA to 10 mA) with high current stability (0.4%). In the device, neutron flux is generated as a result of the ⁷Li(p,n)⁷Be threshold reaction. A beam-shaping assembly is applied to convert this flux into a beam of epithermal neutrons with characteristics suitable for BNCT. A lot of scientific research has been carried out at the facility, including the study of blistering and its effect on the neutron yield. The BNCT technique is being tested in in vitro and in vivo studies, and the methods of dosimetry are being developed. It is planned to certify the neutron source next year and conduct clinical trials on it. The neutron source served as a prototype for a facility created for a clinic in Xiamen (China).

Purpose: To develop an accelerator neutron source suitable for boron neutron capture therapy—a new promising method for treating malignant tumors—and to develop dosimetry tools and methods. Methods: Research into the transport and acceleration of a beam of charged particles, development and manufacture of an accelerator neutron source, study of the radiation generated, and development and implementation of dosimetry tools and methods. Results: A facility called VITA has been created, which includes a tandem electrostatic accelerator of an original design for producing a 2.3 MeV 10 mA proton beam, a lithium target for generating neutrons in the ⁷Li(p,n)⁷Be reaction, and a beam shaping assembly for forming a therapeutic neutron beam. The facility at the institute is used for scientific research, the facility in Xiamen (China) is used for clinical trials, and the facility in Moscow (Russia) will soon be used for clinical trials. Also, new tools and methods for measuring the boron dose, γ-ray dose, and sum of the fast neutron dose and the nitrogen dose have been proposed and implemented. The conducted studies demonstrated the high efficiency of the VITA^® facility, the first possibility of implementing prompt γ-ray spectroscopy for boron imaging, and the first possibility of implementing lithium neutron capture therapy, which has advantages over BNCT, and also presented the results of the development of new tools and methods for measuring the boron dose, γ-ray dose, and the sum of the fast neutron dose and the nitrogen dose. Conclusions: The authors strongly recommend using prompt γ-ray spectroscopy in treatment and developing lithium neutron capture therapy, including in combination with BNCT, and note the high efficiency, reliability and compactness of the VITA^® facility.

Дозиметрия нейтронного потока и гамма-излучения для двух систем формирования пучка нейтронов на установке VITA с использованием сцинтилляционного детектора

Purpose: To develop an accelerator neutron source suitable for boron neutron capture therapy – a new promising method for treating malignant tumors, and to develop dosimetry tools and methods. Methods: Research into the transport and acceleration of a beam of charged particles, development and manufacture of an accelerator neutron source, and study of the radiation generated. Results: A facility called VITA has been created, which includes a tandem electrostatic accelerator of an original design for producing a 2.3 MeV 10 mA proton beam, a lithium target for generating neutrons in the 7Li(p,n)7Be reaction, and a beam shaping assembly for forming a therapeutic neutron beam. Also, tools and methods for measuring the boron dose, -ray dose, and sum of the fast neutron dose and the nitrogen dose have been proposed and created. The conducted studies demonstrated the high efficiency of the VITA facility, the possibility of implementing the prompt -ray spectroscopy for boron imaging, the possibility of implementing lithium neutron capture therapy, which has advantages over BNCT, and also presented the results of the development of tools and methods for measuring the boron dose, -ray dose, and the sum of the fast neutron dose and the nitrogen dose. Conclusion: The authors strongly recommend using the prompt -ray spectroscopy in treatment, developing lithium neutron capture therapy, including in combination with BNCT, and note the high efficiency, reliability and compactness of the VITA facility.